Physician profile
Edward T Lee
NPI 1568589133
$3,546.66
in general payments reported to CMS, 2019-2025
8 companies · $466 in 2025
The $466 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $498 · 2020: $142 · 2021: $441 · 2022: $1,313 · 2023: $311 · 2024: $376 · 2025: $466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,153.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $1,018.01 | 2019-2022 | |
| Neurocrine Biosciences, INC. | $861.87 | 2019-2025 | Ingrezza |
| Alkermes, INC. | $789.49 | 2019-2025 | Lybalvi, Aristada, Aristada Initio |
| Abbvie INC. | $321.09 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $212.13 | 2025 | Cobenfy |
| Preceptis Medical, INC. | $205.97 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $122.27 | 2024 | Uzedy |
| Smith+Nephew, INC. | $15.83 | 2024 | Halo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.